• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

Indapamide Impurity B (1-Amino-2-Methylindoline HCl): An In-Depth Overview

Indapamide Impurity B (1-Amino-2-Methylindoline HCl), with the CAS number 31529-47-2, is a significant compound in the field of pharmaceutical research and development. This impurity is of particular interest due to its potential impact on the efficacy and safety of Indapamide-based medications, which are widely used for the treatment of hypertension and edema. Understanding the chemical properties, synthesis, and analytical methods for detecting this impurity is crucial for ensuring the quality and reliability of pharmaceutical products.

The chemical structure of 1-Amino-2-Methylindoline HCl consists of an indoline ring with a methyl group at the 2-position and an amino group at the 1-position, forming a hydrochloride salt. This structure is closely related to that of Indapamide, which is a sulfonamide diuretic and antihypertensive agent. The presence of this impurity can affect the pharmacokinetic and pharmacodynamic properties of Indapamide, potentially leading to variations in therapeutic outcomes.

Recent studies have highlighted the importance of identifying and quantifying impurities in pharmaceuticals to ensure patient safety and drug efficacy. For instance, a study published in the Journal of Pharmaceutical and Biomedical Analysis (2023) reported the development of a high-performance liquid chromatography (HPLC) method for the detection and quantification of Indapamide Impurity B. This method demonstrated high sensitivity and accuracy, making it a valuable tool for quality control in pharmaceutical manufacturing.

The synthesis of 1-Amino-2-Methylindoline HCl involves several steps, including the formation of an indoline ring, introduction of the methyl group, and subsequent amino group substitution. The reaction conditions, such as temperature, pressure, and catalysts, play a critical role in determining the yield and purity of the final product. Researchers at the University of California, San Francisco (UCSF) have explored various synthetic routes to optimize the production process, focusing on reducing side reactions and improving overall efficiency.

In addition to its role as an impurity in Indapamide-based drugs, 1-Amino-2-Methylindoline HCl has also been studied for its potential biological activities. A study published in the Bioorganic & Medicinal Chemistry Letters (2022) investigated the anti-inflammatory properties of this compound. The results showed that 1-Amino-2-Methylindoline HCl exhibited significant anti-inflammatory effects in vitro, suggesting its potential as a lead compound for developing new therapeutic agents.

The regulatory landscape surrounding pharmaceutical impurities is stringent, with agencies such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) setting strict limits on acceptable levels. The presence of impurities like Indapamide Impurity B must be carefully monitored throughout the drug development process to comply with these regulations. Advanced analytical techniques, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy, are essential for comprehensive characterization and quantification.

In conclusion, Indapamide Impurity B (1-Amino-2-Methylindoline HCl), with CAS number 31529-47-2, is a critical compound in pharmaceutical research due to its potential impact on drug efficacy and safety. Ongoing studies continue to enhance our understanding of its chemical properties, synthesis methods, and biological activities. By leveraging advanced analytical techniques and adhering to regulatory guidelines, researchers can ensure that pharmaceutical products meet the highest standards of quality and reliability.

• 31529-46-1(2-Methylindolin-1-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)